Danielle Owerko

Presenters: Paul Scalici, MD, Meghan Hofto, MD, MPH, DTMH, Lauren Nassetta, MD, James Gambrell, MD During this PHM 2023 session, four pediatric hospitalists tackled a broad topic that many clinicians struggle to stay up to date with—that is, what are all the variably-named substances our teens are using and what do they do to their growing bodies and minds?

Abstract Introduction Neonatal hyperbilirubinemia (NH) is commonly diagnosed and managed by pediatricians in various clinical settings. The 2004 American Academy of Pediatrics (AAP) Clinical Practice Guideline on NH is widely cited, but literature examining variation across pediatric specialties is limited.